An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro

International Immunology

Volumn 8, Issue 7, 1996, Pages 1113-1119

  Latinne, Dominique ^a   De La Parra, Bernardo ^a   Nizet, Yannick ^a   Cornet, Anne ^a   Giovino Barry, Valerie ^b   Monroy, Rodney L ^b   White Scharf, Mary E ^b   Bazin, Hervé ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b BioTransplant Inc   (United States)

Author keywords

CD2; Human T cells; Hyporesponsiveness; Immunosuppression

Indexed keywords

CD2 ANTIGEN; CYTOKINE; GAMMA INTERFERON; LO CD2A; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; CELLS, CULTURED; CLONAL ANERGY; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MUROMONAB-CD3; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030039733     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.7.1113     Document Type: Article

References (30)

1. Yang, S. Y., Chouaib, S. and Dupont, B. 1986. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. J. Immunol. 137:1097.
2. Bockenstedt L. K., Goldsmith, M. A., Dustin, M., Olive, D., Springer, T. A. and Weiss, A. 1988. The CD2 igand LFA-3 activates T cells but depends on the expression and function of the antigen receptor J. Immunol. 141:1904.
3. Moingeon, P., Chang, H. C., Wallner, B. P., Stebbins, C., Frey, A. Z. and Reinherz, E. X. 1989. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 338:312.
4. Huet, S., Wakasugi, H., Sterkers, G., Gilmour, J., Tursz, T., Boumsell, L. and Bernard A. 1986. T cell activation via CD2 (T, gp50): the role of accessory cells in activating resting T cells via CD2. J. Immunol. 137:1420
5. Kabelitz, D. 1990. Do CD2- and CD3-TCR T-cell activation pathways function independently? Immunol. Today 11:44.
6. Holler, W., Majdic, O., Stockinger, H., Howard, B. H. and Knapp, W. 1988. Regulation of the CD2 alternate pathway of T cell activation by CDS, Evidence for heterologous desensitization. J. Immunol. 140:1043.
7. Yssel, H., Aubry, J. P., de Waal Malefijt, R., de Vriez, J. E. and Spits, H. 1987. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. J. Immunol. 139:2850.
8. Ohno, H., Ushiyama, C., Taniguchi, M., Germain, R. N. and Saito, T. 1991. CD2 can mediate TCR/CD3-independent T cell activation. J. Immunol. 146:3742.
9. Jones, E. Y., Davis, S. J., Williams, A. F., Harlos, K. and Stuart, D. I. 1992 Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature 360:232.
10. Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F. and Reinherz, E. L. 1984. An alternative pathway of T cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897.
11. Peterson, A. and Seed, B. 1987. Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2). Nature 329:842.
12. Hughes, C. C. W., Savage, C. O. S. and Pober, J. S. 1990. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J. Exp. Med. 171:1453.
13. Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M. and Feldmann, M. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434.
14. Lamb, J. R., Zanders, E. D., Sewell, W., Crumpton, M. J., Feldmann, M. and Owen, M. J. 1987. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways. Eur. J. Immunol. 17:1641
15. Giorgi, J. V., Burton, R. C., Bareet, L. V., Delmonico, F. L., Goldstein, G. and Cosimi, A. B. 1983. Immunosuppressive effect and immunogenicity of OKT11A monoclonal antibody in monkey allograft recipients. Transplant. Proc. 15:639.
16. Thurlow, P. J., Lovering, E., d'Apice, A. J. and McKenzie, I. F. 1983. A monoclonal anti-pan-T-cell antibody. In vitro and in vivo studies. Transplantation 36:293.
17. Martin, P. J., Longton, G., Ledbetter, J. A., Newman, W., Braun, M. P., Beatty, P. G. and Hansen, J. A. 1983. Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J. Immunol. 131:180.
18. Bazin, H. 1982. Production of rat monoclonal antibodies with the LOU rat non secreting IR983F myeloma cell line. In Peeters, H., ed., Protides of the Biological Fluids, p. 615. Pergamon Press, Oxford.
19. Xia, H, Ravoet, A. M., Latinne, D., Ninane, J., De Bruyère, M., Sokal, G. and Bazin, H. 1990. Rat monoclonal antibodies specific for human T lymphocytes. In Bazin, H., ed., Rat Hybridomas and Rat Monoclonal Antibodies, p. 309 CRC Press, Boca Raton, FL.
20. Bazin, H., Malache, J. M., Nisol, F., Delaunay, T. 1990. Purification of rat monoclonal antibodies from ascitic fluid, serum or culture supernatant. In Bazin, H., ed., Rat Hybridomas and Rat Monoclonal Antibodies, p. 165. CRC Press, Boca Raton, FL.
21. Giovino-Barry, V. C., Latinne, D., Xu, Y., Glasser, R. M., Dickerson, W. M., Matejic, T., Schachter, B. Z., Greenstein, J. L., Bazin, H., White-Scharf, M. E. and Monroy, R. L. 1995. Perturbation of CD2 can induce alloantigen specific hyporesponsiveness in naive T cells. FASEB J. 9:A232 (Abstract 1345).
22. Vincent, C., Fournel, S., Wijdenes, J. and Revillard, J. P. 1995. Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies. Eur. J. Immunol. 25:816.
23. Wolf, H., Müller, Y., Salmen, S., Wilmanns, W. and Jung, G. 1994. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur. J. Immunol. 24:1410.
24. Gückel, B., Berek, C., Lutz, M., Altevogt, P., Schirrmacher, V. and Kyewski, B. A. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174:957.
25. Bromberg, J. S., Chavin, K. D., Altevogt, P., et al. 1991. Anti-CD2 monoclonal antibodies alter cell mediated immunity in vivo. Transplantation 51:219.
26. Chavin, K. D., Lau, H. T. and Bromberg, J. S. 1992. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation, 54:286.
27. Cosimi, A. B., Burton, R. C., Colvin, R. B., Goldstein, G., Delmonico, F. L., La Quaglia, M. P., Tolkoff-Rubin, N., Rubin, R. H., Herrin, J. T. and Russel, P. S. 1981. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32:535.
28. Ortho Multicenter Transplant Group. 1985. Use of monoclonal antibodies to T-cell subsets for immunologie monitoring and treatment in recipients of renal allografts. N. Engl J. Med. 313:337.
29. Parlevliet, K. J. and Schellekens, P. T. A. 1992. Monoclonal antibodies in renal transplantation: a review. Transplant. Int. 5:234.
30. Masroor, S., Schroeder, T. J., Michler, R. E., Alexander, J. W. and First, M. R. 1994. Monoclonal antibodies in organ transplantation: an overview. Transplant. Immunol. 2:176.